COMP <GO>
UFPT vs INSP // 10Y YIELD & FRED MACRO BETA
UFP Technologies Inc. (NASDAQ) VS. Inspire Medical Systems Inc. (NYSE) • 15-METRIC TALLY: UFPT 6
— INSP 6
■ METRIC PARITY
LAST: $284.50 (-3.00%) • MKT CAP: $2.27B
macro-sensitivity
—
LAST: $68.10 (-4.33%) • MKT CAP: $2.06B
macro-sensitivity
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (UFPT VS. INSP)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | UFPT | INSP | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 28.30% | 85.40% | -57.10 | INSP | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 13.90% | 6.00% | +7.90 | UFPT | /roic <GO> |
| EV/EBITDA & P/E Valuation | 25.7x | 23.3x | +2.40 | INSP | /valuation <GO> |
| Free Cash Flow Yield | 4.05% | 3.81% | +0.24 | UFPT | /fcf-yield <GO> |
| Operating Margin | 15.30% | 5.60% | +9.70 | UFPT | /operating-margins <GO> |
| Net Profit Margin | 11.30% | 15.90% | -4.60 | INSP | /net-margins <GO> |
| Revenue Growth (YoY) | 19.50% | 13.60% | +5.90 | UFPT | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 8.31 | 11.40 | -3.09 | INSP | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 7/9 | +2.00 | UFPT | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 51.0 | 53.5 | -2.50 | INSP | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 28.0x | 11.9x | +16.10 | INSP | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.27B | $2.06B | $214.0M | UFPT | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | UFPT REV | INSP REV | UFPT GROSS % | INSP GROSS % | UFPT FCF | INSP FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $602.8M | $912.0M | 28.3% | 85.4% | $91.9M | $78.5M |
| FY 2024 | $504.4M | $802.8M | 29.1% | 84.7% | $56.9M | $91.1M |
| FY 2023 | $400.1M | $624.8M | — | — | $41.3M | $24.7M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
UFPT // BETA —
INSP // BETA —